# European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide - The Manila Times

*Источник: The Manila Times*
*Дата: 2026-09-21*
*Язык: en*

<a href="https://news.google.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?oc=5" target="_blank">European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide</a>&nbsp;&nbsp;<font color="#6f6f6f">The Manila Times</font>

[Оригинал](https://www.manilatimes.net/2026/09/21/tmt-newswire/globenewswire/european-commission-approval-of-icotydeicotrokinra-ushers-in-new-era-for-first-line-systemic-treatment-of-plaque-psoriasis-with-a-targeted-oral-peptide/2429640)